Literature DB >> 2457587

Recombinant interleukin 6 regulates the transcriptional activation of a set of human acute phase genes.

G Morrone1, G Ciliberto, S Oliviero, R Arcone, L Dente, J Content, R Cortese.   

Abstract

The phenomenon of acute phase (AP) response can be reproduced in vitro using cultured cells of hepatic origin by stimulation with the crude supernatant of activated monocytes (MoCM). Several monocyte-derived factors have been identified which might be responsible, alone or in combination, for the induction of AP response, but recently the attention has been focused on interleukin 6 (IL-6). We have previously shown that part of the AP response consists of the increase in the rate of transcription of the AP genes. Here we have treated the human hepatoma cell line Hep 3B with either crude MoCM or recombinant IL-6 and compared the effect of the two stimulants on the expression of both endogenous AP genes and recombinant plasmids introduced into the cells by transfection. The transfected plasmids contained the 5'-flanking region of AP genes fused to the coding region of the bacterial chloramphenicol acetyltransferase gene. We observe that the induction of mRNA accumulation of the endogenous genes corresponds to the transcriptional activation of the chloramphenicol acetyltransferase fusions. This is good evidence that the effect of IL-6 is totally or partially exerted at the level of transcription and that short segments of the 5'-flanking sequences of the inducible genes contain IL-6-responsive elements. Our results show that IL-6 is fully effective only on some of all the genes induced or repressed by MoCM, whereas others are only partially affected or totally nonresponsive.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2457587

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Opioid receptor gene: cytokine response element and the effect of cytokines.

Authors:  H J Im; S W Kang; H H Loh
Journal:  Brain Res       Date:  1999-05-22       Impact factor: 3.252

Review 2.  Interleukin-6 and the acute phase response.

Authors:  P C Heinrich; J V Castell; T Andus
Journal:  Biochem J       Date:  1990-02-01       Impact factor: 3.857

3.  Binding of a liver-specific factor to the human albumin gene promoter and enhancer.

Authors:  M Frain; E Hardon; G Ciliberto; J M Sala-Trepat
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

4.  Stimulation of CRP secretion in HepG2 cells: cooperative effect of dexamethasone and interleukin 6.

Authors:  S Depraetere; J Willems; M Joniau
Journal:  Agents Actions       Date:  1991-11

5.  Pro-inflammatory cytokine release and mediation of the acute phase protein response in fulminant hepatic failure.

Authors:  S J Wigmore; T S Walsh; A Lee; J A Ross
Journal:  Intensive Care Med       Date:  1998-03       Impact factor: 17.440

6.  Quantitative intracellular cytokine measurement: age-related changes in proinflammatory cytokine production.

Authors:  L O'Mahony; J Holland; J Jackson; C Feighery; T P Hennessy; K Mealy
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

7.  The two C/EBP isoforms, IL-6DBP/NF-IL6 and C/EBP delta/NF-IL6 beta, are induced by IL-6 to promote acute phase gene transcription via different mechanisms.

Authors:  D P Ramji; A Vitelli; F Tronche; R Cortese; G Ciliberto
Journal:  Nucleic Acids Res       Date:  1993-01-25       Impact factor: 16.971

8.  Saturation mutagenesis of the human interleukin 6 receptor-binding site: implications for its three-dimensional structure.

Authors:  R Savino; A Lahm; M Giorgio; A Cabibbo; A Tramontano; G Ciliberto
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

9.  Hyperthermic isolated limb perfusion increases circulating levels of inflammatory cytokines.

Authors:  T D Quinn; H C Polk; M J Edwards
Journal:  Cancer Immunol Immunother       Date:  1995-04       Impact factor: 6.968

Review 10.  Host defense against infections and inflammations: role of the multifunctional IL-6/IFN-beta 2 cytokine.

Authors:  M Revel
Journal:  Experientia       Date:  1989-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.